RT @CashRocket: Cancer’s Invasion Equation https://t.co/1II1nurWPb
FANTASTIC ARTICLE $MRK $BMY $INCY
RT @fezziwig2008: $MRK wil be bigger for $HALO earnings than was $BMY https://t.co/NTkx6tA2jY
RT @MttsTrading: MTTS Daily Watch List for October 17, 2017 $KSS $NKE $SHOP $HRS $BMY $LITE $CRUS https://t.co/E0fT0fmiia
MTTS Daily Watch List for October 17, 2017 $KSS $NKE $SHOP $HRS $BMY $LITE $CRUS https://t.co/E0fT0fmiia
RT SeekingAlpha "https://t.co/KkIWU13D9l $ALNY $BAYN $BMY $EXEL $IONS"
https://t.co/tzIgRtXDje $ALNY $BAYN $BMY $EXEL $IONS
Bristol-Myers Squibb Company $BMY Holdings Maintained by British Airways Pensions Investment Management Ltd https://t.co/YPNKVY6I8c
Bristol-Myers Squibb Company $BMY Holdings Held by Pineno Levin & Ford Asset Management Inc. https://t.co/3ZwT3Aempn
Bristol-Myers Squibb Company $BMY Holdings Maintained by British Airways Pensions Investment Management Ltd https://t.co/jiQVLBdEkF
Bristol-Myers Squibb Company $BMY Holdings Held by Pineno Levin & Ford Asset Management Inc. https://t.co/HBn8P8bq8C
Bristol-Myers Squibb Company $BMY Stake Increased by Advisor Partners LLC https://t.co/jxzF0NlBsV
Bristol-Myers Squibb Company $BMY Stake Increased by Advisor Partners LLC https://t.co/SeOU6JF2kc
Bristol-Myers Squibb Company $BMY Holdings Maintained by British Airways Pensions Investment Management Ltd https://t.co/7E6lIAZ9Il
Bristol-Myers Squibb Company $BMY Holdings Held by Pineno Levin & Ford Asset Management Inc. https://t.co/uo53AacRsd
Bristol-Myers Squibb Company $BMY Position Increased by Goelzer Investment Management Inc. https://t.co/Af00Rcs5eE
Bristol-Myers Squibb Company $BMY Position Lifted by Cliftonlarsonallen Wealth Advisors LLC https://t.co/j2t2W1z7i7
TD Asset Management Inc. Sells 106,279 Shares of Bristol-Myers Squibb Company $BMY https://t.co/oUFbOeOXEW
Bristol-Myers Squibb Company $BMY Holdings Maintained by British Airways Pensions Investment Management Ltd https://t.co/o450GO5wrJ
Bristol-Myers Squibb Company $BMY Holdings Held by Pineno Levin & Ford Asset Management Inc. https://t.co/TZWwHp0u6e
Bristol-Myers Squibb Company $BMY Position Increased by Goelzer Investment Management Inc. https://t.co/8DIw4f9f2H
Bristol-Myers Squibb Company $BMY Position Lifted by Cliftonlarsonallen Wealth Advisors LLC https://t.co/VOICOtnc1A
#NICE approves $BMY OPDIVO for funding through the #CancerDrugsFund in head and neck #cancer https://t.co/6s4VYuWlAE
Barclays PLC Raises Bristol-Myers Squibb Company $BMY Price Target to $65.00 https://t.co/dFiJe14K0A
Barclays PLC Raises Bristol-Myers Squibb Company $BMY Price Target to $65.00 https://t.co/oTqRp4MScH
Barclays PLC Raises Bristol-Myers Squibb Company $BMY Price Target to $65.00 https://t.co/FY4UGO8e0b
Barclays PLC Raises Bristol-Myers Squibb Company $BMY Price Target to $65.00 https://t.co/kOA6tFTREV
BMY Top news - Oct 16th, 2017 $BMY http://https://t.co/mVMeo2Ok5T
$INCY claims $BMY #IDO medication stolen by ex-staffer set for trial hearing #NSCLC #bladdercancer #pharma #biotech https://t.co/bGtDR3SlKK
$BMY shows a nice relative overall strength https://t.co/xfF6gsZ91s #moon #Diwali2017
RT @odibro: $BMY FDA Accepts App. for Opdivo in Patients with Resected High-Risk Advanced Melanoma and Grants Priority Review https://t.co/…
RT @JSTBiotech: RJ note out on $LPTX: likening TRX518's (anti-GITR) combo potential to $INCY IDO Epacadostat; also likely superior efficacy…
RT @dhovekamp42: $BMY Wow again: FDA Accepts Opdivo in Patients with Resected High-Risk Advanced Melanoma and Grants Priority Review https:…
RT @dhovekamp42: $BMY Wow again: FDA Accepts Opdivo in Patients with Resected High-Risk Advanced Melanoma and Grants Priority Review https:…
@LeederOfThePack @TheStalwart What does that mean to the earnings of $BMY ?
RT @tgtxdough: NOMURA $FPRX BUY PT 92 - very bullish comments - CSF1R potential $BMY https://t.co/lrYVWRi57c
$BMY after downgrade today, FDA grants accelerated review for Bristol-Myers' Opdivo for melanoma.
FDA Accepts $BMY ’s Application for Opdivo in Resected High-Risk Advanced Melanoma Patients, Grants Priority Review https://t.co/jSve3h47G7
RT @BioStocks: $INCY Might Win a Cancer-Drug Battle But Lose the War
https://t.co/4uwoePh6qD $BMY
RT @BioStocks: $INCY Might Win a Cancer-Drug Battle But Lose the War
https://t.co/4uwoePh6qD $BMY
https://t.co/M8fzGrLzoR $CTMX covering each on of their collab. preclin projects at AACR-NCI-EORTC: $ABBV CD71, $BMY CTLA-4 & $AMGN CD3xEGFR
$INCY Might Win a Cancer-Drug Battle But Lose the War
https://t.co/4uwoePh6qD $BMY
Commented on https://t.co/PfXNUNnRrh $AGN $BMY $CNAT $GALT $GNFTF $MRK $ICPT
RT SeekingAlpha: https://t.co/MfUQDOZxXN $ALNY $BAYN $BMY $EXEL $IONS
Commented on https://t.co/xeGqZIiNz7 $AGN $BMY $CNAT $GALT $GNFTF $MRK $ICPT
Commented on https://t.co/FOW0ke0Qmb $AGN $BMY $CNAT $GALT $GNFTF $MRK $ICPT
Commented on https://t.co/x1jlFuKdJ1 $AGN $BMY $CNAT $GALT $GNFTF $MRK $ICPT
Commented on https://t.co/8Kq6z87VaH $AGN $BMY $CNAT $GALT $GNFTF $MRK $ICPT
$BMY: The recommendation for Bristol-Myers Squibb Co has been downgraded to Hold. (https://t.co/CRZEjsqkV1)
Waddell & Reed Financial Has Trimmed Its Bristol Myers Squibb Co $BMY Position https://t.co/shMi5RcKj1